IGC Pharma (IGC) Acquisitions (2011 - 2019)
IGC Pharma (IGC) reported Acquisitions of $19000.0 for Q3 2019, up 137.5% year-over-year from $8000.0 in Q3 2018, and up 375.0% quarter-over-quarter from $4000.0 in Q2 2019.
IGC Pharma (IGC) Acquisitions (2011 - 2019) Analysis & Trends
IGC Pharma (IGC) has 8 years of Acquisitions data on file, last reported at $19000.0 in Q3 2019.
- Acquisitions for Q3 2019 came in at $19000.0, up 137.5% year-over-year; the trailing twelve-month figure through Sep 2019 was $55000.0 (up 193.22% YoY), and the FY2019 annual result was $45000.0, down 30.77% from the prior year.
- Acquisitions improved to $19000.0 in Q3 2019 per IGC's latest filing, from $4000.0 in the prior quarter.
- Over five years, Acquisitions peaked at $149000.0 in Q4 2017 and troughed at -$221000.0 in Q1 2018.
- A 5-year average of $146.17 and a median of $4500.0 in 2018 frame the typical range for Acquisitions.
- The sharpest annual moves came in 2016 and 2019: Acquisitions plunged 3862.56% in 2016, then soared 137.5% in 2019.
- A 5-year view of Acquisitions shows it stood at -$414.0 in 2015, then sank by 3862.56% to -$16405.0 in 2016, then surged by 1008.26% to $149000.0 in 2017, then slumped by 80.54% to $29000.0 in 2018, then tumbled by 34.48% to $19000.0 in 2019.
- Business Quant data shows IGC's Acquisitions at $19000.0 in Q3 2019, $4000.0 in Q2 2019, and $3000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 19,000.00 |
| Jun 30, 2019 | 4,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Dec 31, 2018 | 29,000.00 |
| Sep 30, 2018 | 8,000.00 |
| Jun 30, 2018 | 5,000.00 |
| Mar 31, 2018 | -221,000.00 |
| Dec 31, 2017 | 149,000.00 |
| Sep 30, 2017 | 137,000.00 |
| Mar 31, 2017 | -114,427.00 |
| Mar 31, 2016 | -16,405.00 |
| Mar 31, 2015 | -414.00 |
| Dec 31, 2014 | -154.00 |
| Sep 30, 2014 | 1,576.00 |
| Jun 30, 2014 | -166,916.00 |
| Sep 30, 2012 | -308,255.00 |
| Dec 31, 2011 | -2.68 Mn |